Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionFounders Capital Management
Latest Disclosed Ownership512 shares
Latest Disclosed Value $ 71,357
Founders Capital Management reports 36.95% decrease in ownership of GILD / Gilead Sciences, Inc.

On April 21, 2026 - Founders Capital Management filed a 13F-HR form disclosing ownership of 512 shares of Gilead Sciences, Inc. (CH:GILD) valued at $71,357 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 15, 2026 disclosing 812 shares of Gilead Sciences, Inc.. This represents a change in shares of -36.95% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F GILEAD SCIENCES COM 375558103 512 -300 -36.95 71 -28.28 0.0348
2026-01-15 2025-12-31 13F GILEAD SCIENCES COM 375558103 812 0 0.00 100 10.00 0.0518
2025-11-13 2025-09-30 13F GILEAD SCIENCES COM 375558103 812 0 0.00 90 0.00 0.0478
2025-07-18 2025-06-30 13F GILEAD SCIENCES COM 375558103 812 -200 -19.76 90 -20.35 0.0540
2025-04-08 2025-03-31 13F GILEAD SCIENCES COM 375558103 1,012 0 0.00 113 21.51 0.0734
2025-01-13 2024-12-31 13F GILEAD SCIENCES COM 375558103 1,012 0 0.00 93 10.71 0.0592
2024-10-07 2024-09-30 13F GILEAD SCIENCES COM 375558103 1,012 0 0.00 85 21.74 0.0517
2024-07-10 2024-06-30 13F GILEAD SCIENCES COM 375558103 1,012 0 0.00 69 -6.76 0.0450
2024-04-10 2024-03-31 13F GILEAD SCIENCES COM 375558103 1,012 0 0.00 74 -8.64 0.0501
2024-01-08 2023-12-31 13F GILEAD SCIENCES COM 375558103 1,012 0 0.00 82 8.00 0.0596
2023-10-10 2023-09-30 13F GILEAD SCIENCES COM 375558103 1,012 0 0.00 76 -2.60 0.0579
2023-07-07 2023-06-30 13F GILEAD SCIENCES COM 375558103 1,012 0 0.00 78 0.0567
2023-04-12 2023-03-31 13F GILEAD SCIENCES COM 375558103 1,012 0 0.00 0 0.0642
2023-01-09 2022-12-31 13F GILEAD SCIENCES COM 375558103 1,012 -100 -8.99 0 -100.00 0.0654
2022-10-06 2022-09-30 13F GILEAD SCIENCES COM 375558103 1,112 0 0.00 69 0.00 0.0563
2022-07-20 2022-06-30 13F GILEAD SCIENCES COM 375558103 1,112 112 11.20 69 -5.48 0.0544
2022-04-07 2022-03-31 13F GILEAD SCIENCES COM 375558103 1,000 0 0.00 73 0.00 0.0468
2022-01-21 2021-12-31 13F GILEAD SCIENCES COM 375558103 1,000 0 0.00 73 4.29 0.0468
2021-10-12 2021-09-30 13F GILEAD SCIENCES COM 375558103 1,000 0 0.00 70 1.45 0.0480
2021-07-15 2021-06-30 13F GILEAD SCIENCES COM 375558103 1,000 0 0.00 69 6.15 0.0450
2021-06-09 2021-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 1,000 100 11.11 65 25.00 0.0463
2021-06-07 2021-03-31 13F GILEAD SCIENCES COM 375558103 1,000 100 6 0.0658
2021-01-12 2020-12-31 13F GILEAD SCIENCES COM 375558103 900 0 0.00 52 -22.39 0.0368
2020-04-22 2020-03-31 13F GILEAD SCIENCES COM 375558103 900 300 50.00 67 71.79 0.0695
2020-01-24 2019-12-31 13F GILEAD SCIENCES COM 375558103 600 0 0.00 39 2.63 0.0295
2019-10-10 2019-09-30 13F GILEAD SCIENCES COM 375558103 600 0 0.00 38 -7.32 0.0304
2019-07-11 2019-06-30 13F GILEAD SCIENCES COM 375558103 600 0 0.00 41 5.13 0.0362
2019-04-17 2019-03-31 13F GILEAD SCIENCES COM 375558103 600 200 50.00 39 56.00 0.0366
2019-01-14 2018-12-31 13F GILEAD SCIENCES COM 375558103 400 0 0.00 25 -19.35 0.0267
2018-10-05 2018-09-30 13F GILEAD SCIENCES COM 375558103 400 0 0.00 31 10.71 0.0256
2018-07-09 2018-06-30 13F GILEAD SCIENCES COM 375558103 400 0 0.00 28 -6.67 0.0246
2018-04-09 2018-03-31 13F GILEAD SCIENCES COM 375558103 400 0 0.00 30 3.45 0.0253
2018-01-22 2017-12-31 13F GILEAD SCIENCES COM 375558103 400 0 0.00 29 -9.37 0.0241
2017-10-17 2017-09-30 13F GILEAD SCIENCES COM 375558103 400 0 0.00 32 14.29 0.0265
2017-07-19 2017-06-30 13F GILEAD SCIENCES COM 375558103 400 100 33.33 28 40.00 0.0248
2017-05-09 2017-03-31 13F GILEAD SCIENCES COM 375558103 300 300 20 0.0180
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.